IL100599A - Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them - Google Patents

Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL100599A
IL100599A IL10059992A IL10059992A IL100599A IL 100599 A IL100599 A IL 100599A IL 10059992 A IL10059992 A IL 10059992A IL 10059992 A IL10059992 A IL 10059992A IL 100599 A IL100599 A IL 100599A
Authority
IL
Israel
Prior art keywords
inetermediates
preparation
pharmaceutical compositions
compositions containing
alkenoic acid
Prior art date
Application number
IL10059992A
Other languages
English (en)
Other versions
IL100599A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL100599A0 publication Critical patent/IL100599A0/xx
Publication of IL100599A publication Critical patent/IL100599A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL10059992A 1991-01-10 1992-01-07 Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them IL100599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100493A GB9100493D0 (en) 1991-01-10 1991-01-10 Substituted alkenoic acid and its derivatives

Publications (2)

Publication Number Publication Date
IL100599A0 IL100599A0 (en) 1992-09-06
IL100599A true IL100599A (en) 1997-02-18

Family

ID=10688219

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10059992A IL100599A (en) 1991-01-10 1992-01-07 Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US5246966A (da)
EP (1) EP0494621B1 (da)
JP (1) JPH04321663A (da)
KR (1) KR920014775A (da)
AT (1) ATE125793T1 (da)
AU (1) AU643355B2 (da)
CA (1) CA2058884A1 (da)
CZ (1) CZ286679B6 (da)
DE (1) DE69203732T2 (da)
DK (1) DK0494621T3 (da)
ES (1) ES2076559T3 (da)
FI (1) FI920075A (da)
GB (1) GB9100493D0 (da)
GR (1) GR3017031T3 (da)
HU (2) HU213475B (da)
IE (1) IE920073A1 (da)
IL (1) IL100599A (da)
MY (1) MY108136A (da)
PL (2) PL168848B1 (da)
RU (1) RU2058979C1 (da)
ZA (1) ZA92142B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523946D0 (en) * 1995-11-23 1996-01-24 Bayer Ag Leukotriene antagonistic benzoic acid derivatives
DE19943636A1 (de) * 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
GB2218416A (en) * 1988-05-13 1989-11-15 Bayer Ag Leukotriene disease antagonists
EP0410241B1 (en) * 1989-07-27 1993-10-20 Bayer Ag Aryl alkenoic acid derivatives as leukotriene antagonists

Also Published As

Publication number Publication date
RU2058979C1 (ru) 1996-04-27
EP0494621A1 (en) 1992-07-15
CZ286679B6 (cs) 2000-06-14
CA2058884A1 (en) 1992-07-11
US5246966A (en) 1993-09-21
AU1012292A (en) 1992-07-16
GR3017031T3 (en) 1995-11-30
IL100599A0 (en) 1992-09-06
DE69203732T2 (de) 1996-01-18
CS7492A3 (en) 1992-08-12
ES2076559T3 (es) 1995-11-01
ATE125793T1 (de) 1995-08-15
HU213475B (en) 1997-06-30
ZA92142B (en) 1992-09-30
HUT60469A (en) 1992-09-28
HU9200090D0 (en) 1992-03-30
PL293117A1 (en) 1992-12-28
EP0494621B1 (en) 1995-08-02
IE920073A1 (en) 1992-07-15
HU211553A9 (en) 1995-12-28
KR920014775A (ko) 1992-08-25
DK0494621T3 (da) 1995-12-27
JPH04321663A (ja) 1992-11-11
DE69203732D1 (de) 1995-09-07
GB9100493D0 (en) 1991-02-20
MY108136A (en) 1996-08-15
FI920075A0 (fi) 1992-01-08
AU643355B2 (en) 1993-11-11
PL169083B1 (pl) 1996-05-31
PL168848B1 (pl) 1996-04-30
FI920075A (fi) 1992-07-11

Similar Documents

Publication Publication Date Title
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
HUT52770A (en) Process for producing new 2-amino-pyrimidinone derivatives and pharmaceutical compositions containing them
AU7436691A (en) Novel 2,9-disubstituted-4H-pyrido(1,2-a)pyrimidin-4-ones
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
IL100599A (en) Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
AU1659192A (en) Novel 2h-benzo(b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
DE69222143D1 (de) Indanderivate
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
HUT45059A (en) Process for producing abeoergoline derivatives
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
HUT58721A (en) Process for producing indolyl derivatives and pharmaceutical compositions containing them as active components
EP0337765A3 (en) Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees